s******i
发帖数: 350 | 1 Dvax Vaccination FDA 明年二月审批.它的乙肝疫苗在一个月内只需接种两次，而现有
疫苗需半年接种三次.DVAX的疫苗比传统的效果更好.我买了两千股.今天CRTX升的太快
了,我觉得以后的油水不大了，今我把它卖了,转战DVAX.
Dvax 很有潜力爆发. |
|
g****e
发帖数: 1426 | 2 Due to the high risk and reward, it is hard to resist to gamble. But never
play up and down like MM!! Since MM have insider knowledges and huge funds
to manipulate share price! The only advantage we have is time. We know the
FDA decision event is coming and should buy these stocks
When the price is low ahead of time! The price will eventually go up when
the catalyst event is approaching and then we sell for gains.
Currently I have long position on AMRN, DCTH, AEGR & DVAX. Among these 4,
AMRN is ... 阅读全帖 |
|
k********8
发帖数: 7948 | 3 靠，我看到DVAX头就大
我老婆不炒股，但不知道从哪儿听来了DVAX，天天在我耳边说DVAX this and that,我
都要烦死了！！ |
|
c*******1
发帖数: 5 | 4 Dvax疫苗明年初FDA决定是否批准,所以在这之前股价的趋势会有很大上升. 从过去的
FDA批准的ARNA或SUPN等可以看出现在是买DVAX的好时机,然后在手中捂上四五个月再卖
,估计可以赚不少.我买了一些,准备捂到年底大赚.
CRTX的FDA时间是十月份,所以现在是买入好时机,怕风险的十月初等涨得差不多就可卖,
因为FDA决定日前后几日是大动荡时.可以参考ARNA曲线看股价与FDA决定日的关系 |
|
f*******1
发帖数: 1308 | 5 DVAX 终于宣布以15美元的价格增发5百万股新股。 想买的可以设15或者更低一点买了。
BERKELEY, CA--(Marketwired - August 09, 2017) - Dynavax Technologies
Corporation (DVAX) today announced the pricing of a previously announced
underwritten public offering of 5,000,000 shares of its common stock,
offered at a price to the public of $15.00 per share. |
|
发帖数: 1 | 6 刚才DVAX的老套路又来了一般，晚上鸟不巧地盘前拉起，早上就砸盘，结束前在买入，
哎，DVAX的这个庄真好玩 |
|
g****e
发帖数: 1426 | 7 HZNP is running like ARNA, will run to 7 as approach Pdufa date 07/26.
Dvax lower low and higher high, expecting FDA Announcement about NDA
acceptance next week. Just had dilution at 4.25 and Pdufa date 10/26. Don't
miss them, do you own DD. |
|
g****e
发帖数: 1426 | 8 Hope you had good time with HZNP. As for DVAX, if FDA grant priority review,
which I think should have 90 percent chance, we will easily see close to $5
This week since that means drug potentially 4 months earlier in the mark.
Finger across and good luck. |
|
|
g****e
发帖数: 1426 | 9 DVAX news is out. Enjoy the run. |
|
c*******1
发帖数: 5 | 10 Dvax FDA明年二月审批的是其乙肝疫苗,它比现有疫苗有着更强更早的预防作用而且剂
量更低.所以很有希望被批准.现在买入等涨高后明年一月份卖掉一部分先赚些钱,留一
部分赌FDA批准它的疫苗,我觉得不错. 今年七八月有不少新药等待FDA批准,可能会帯动
九十月份待批的药生物技朮股价的攀升,所以可以再买入九十月份待批药的股票.不能等
着升高后再买,那样的话就错失良机了. |
|
s******i
发帖数: 350 | 11 http://www.pipelinereview.com/index.php/2012072448524/Vaccines/
BERKELEY, CA, USA I July 24, 2012
DVAX submitted a Marketing Authorization Application (MAA) to the European
Medicines Agency (EMA) pursuing an indication for immunization against
infection caused by all known subtypes of hepatitis B virus in adults 18
through 70 years of age and in patients with chronic kidney disease. |
|
s******i
发帖数: 350 | 12 先后两次买了两千股.这是一支非常有潜力的股.
九点半时查到涨1.36百分点,我认为近期还有更大的上升空间,
远期(年底)有火箭上冲的势头. 它不会受欧债影响，所以可以放心买入。
以前我推荐买CRTX,但这两天涨了十个百分点,所以今天我建议早点脱手CRTX,不要太贪.
现在转战DVAX,因为它的价位在五以下,这支股冲出五是很可能发生的,年底可能会直逼
十. |
|
|
g****e
发帖数: 1426 | 14 Bought dvax @3.7x today. Currently holding these 4 biotech stock long
position. |
|
f*******1
发帖数: 1308 | 15 DVAX, CALI, DNDN, INFI.... |
|
P********6
发帖数: 709 | 16 DVAX是研发泄药的吗？拉个没完了？人都要虚脱了。 |
|
|
a*****i
发帖数: 2108 | 18 昨天一念之差没捞点FOSL。不过还是要淡定，赌心不能常有，小赌怡情。得好好考虑下
要不要把DVAX hold过8月的FDA审查。 |
|
|
发帖数: 1 | 20 28号宣布PEUFa结果
DVAX
$10.06
+0.46 (+4.73%) HEPLISAV-B
Hepatitis B
PDUFA 07/28/2017
CRL February 25, 2013 and November 14, 2016. New PDUFA August 10, 2017.
Advisory Committee Meeting July 28, 2017. |
|
t****t
发帖数: 273 | 21 你觉得DVAX后面这一两个月会怎么走？
我也觉得非常奇怪。唯一的问题是听说可能会发行新股。好消息是FDA批准基本是铁板
钉钉的事情。前面几天做空的人很多。而且他家还有个SD101治疗癌症的药前面两期试
验的数据也非常。
实在觉得奇怪为啥能从盘前最高的$20跌成这样。 |
|
r*******4
发帖数: 1484 | 22 The only explanation I can come up with is MM is trying to use the overhang
of a small chance of FDA rejection on 8/10 to scare people to sell 8/17
calls before 8/10 to limit the payout. After that there should be no hurdle
for the stock price to leap up.
Loaded more at 16 today. After the FDA approval I expect Merck or GSK will
knock on the door. DVAX CEO is an ex-GSK executive. GSK is currently
marketing the only hepatitis-B vaccine available. Merck was one time co-
developing Hepasaliv-B wi... 阅读全帖 |
|
f*******1
发帖数: 1308 | 23 药牛，玩小药股得有一颗强大的心脏，像DVAX, EDIT, NTLA, CRSP, AGEN, CALA这样子
的，一有点风吹草动，一天10％甚至20％就上下了， 没有强大的心脏，早被晃晕了。
呵呵。 |
|
发帖数: 1 | 24 我看了有个大户跑了1万股跑了,真没出息..
1万股DVAX引起的大跳水... |
|
|
发帖数: 1 | 26 原文是这样的：
BERKELEY, CA -- (Marketwired) -- 08/08/17 -- Dynavax Technologies
Corporation (NASDAQ: DVAX) today announced that it intends to offer and sell
$125.0 million of shares of its common stock, subject to market and other
conditions, in an underwritten public offering. Dynavax also expects to
grant the underwriters a 30-day option to purchase up to an additional $18.
75 million of shares of its common stock to cover over-allotments
就是说打算增发，还没增发。 |
|
|
r*******4
发帖数: 1484 | 28 这个股有戏。不过你要进的话不是博它 FDA approval。现在Adcom 投票一边倒，
approval没问题了，已经price in。
这个药是疫苗，不是一般的NDA，是BLA。BLA的exclusivity比NDA长得多。而且即便
exclusivity和专利都过期，生物药的manufacturing不容易重复，仿制药的门槛很大。
这个药在hepatitis B方面只有GSK的一个疫苗和它竞争。可是它比GSK的疫苗有效得多
，而且只要两剂一个月，而GSK的疫苗要三剂六个月，很不方便。所以很可能会成为
standard of care。GSK的那个疫苗现在一年差不多卖一个billion。而且hepatitis B
发病率在增长。
DVAX还有一个值钱的cancer drug candidate sd101，一二期预结果很好。
它现在的盘后市值一个billion都不到。要稀释一下就算一个billion，也很低。很可能
大公司像GSK会对它有兴趣。到时收买价再翻一倍也就两个billion，不算太贵。 |
|
s*******o
发帖数: 951 | 29 赞分析，我觉得去45问题不大，不过自己肯定也拿不住
: 这个股有戏。不过你要进的话不是博它 FDA approval。现在Adcom 投票一边倒，
: approval没问题了，已经price in。
: 这个药是疫苗，不是一般的NDA，是BLA。BLA的exclusivity比NDA长得多。而且
即便
: exclusivity和专利都过期，生物药的manufacturing不容易重复，仿制药的门槛
很大。
: 这个药在hepatitis B方面只有GSK的一个疫苗和它竞争。可是它比GSK的疫苗有
效得多
: ，而且只要两剂一个月，而GSK的疫苗要三剂六个月，很不方便。所以很可能会
成为
: standard of care。GSK的那个疫苗现在一年差不多卖一个billion。而且
hepatitis B
: 发病率在增长。
: DVAX还有一个值钱的cancer drug candidate sd101，一二期预结果很好。
: 它现在的盘后市值一个billion都不到。要稀释一下就算一个billion... 阅读全帖 |
|
f*******1
发帖数: 1308 | 30 赞很靠谱的分析。 补充一个，DVAX的后面的大庄家极其强悍，曾经短时间内把ACHN从2
块多暴力拉到20的。
B |
|
|
|
发帖数: 1 | 33 已经加了，这次大跌让我看到DVAX的虚弱。迭起来根本没有能力组织有效的反攻。
我不知道是不是股版在做空。希望不是...
了。 |
|
发帖数: 1 | 34 二楼可拍砖
DVAX
$21.70
+1.45 (+7.16%) HEPLISAV-B
Hepatitis B
PDUFA 11/10/2017
CRL February 25, 2013 and November 14, 2016. Original PDUFA date set for
August 10, 2017 but noted August 3, 2017 a 3-month extension to August 10.
Advisory Committee Meeting July 28, 2017 voted 21 -1 in favor of
recommending approval. |
|
发帖数: 1 | 35 凡事皆有可能啊，今年唯一犹豫错过上车机会的就是DVAX了，7刀的时候犹豫了好久没
上，然后再也上不去了... |
|
|
P********6
发帖数: 709 | 37 Dynavax Announces Acceptance of Two Data Abstracts for SD-101 in Combination
with KEYTRUDA® for Presentation at the 2018 Ameri
2018-03-15 10:30:02.354 GMT
Dynavax Announces Acceptance of Two Data Abstracts for SD-101 in Combination
with KEYTRUDA® for Presentation at the 2018 American Association for
Cancer Research (AACR) Annual Meeting
Data from Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
(HNSCC)
Durability Data in... 阅读全帖 |
|
|
P********6
发帖数: 709 | 39 Over the past 7 days, Dynavax Technologies Corporation (NASDAQ:DVAX) stock
has increased in price by 15.35%. Looking backwards over the past quarter,
these shares have fell -12.41%. Turning to look at the last 6 months, this
stock has dropped 27.41% to its price. Since the beginning of the calendar
year, this stock has moved down by 49.78%. |
|
|
|
P********6
发帖数: 709 | 42 为什么季报这么差还涨？因为疫苗被6个销售商接纳了吗？
Over the past 7 days, Dynavax Technologies Corporation (NASDAQ:DVAX) stock
has increased in price by 15.35%. Looking backwards over the past quarter,
these shares have fell -12.41%. Turning to look at the last 6 months, this
stock has dropped 27.41% to its price. Since the beginning of the calendar
year, this stock has moved down by 49.78%. |
|
P********6
发帖数: 709 | 43 为什么季报这么差还涨？因为疫苗被6个销售商接纳了吗？
数据利好的时候大跌，现在数据不好却大涨。
Over the past 7 days, Dynavax Technologies Corporation (NASDAQ:DVAX) stock
has increased in price by 15.35%. Looking backwards over the past quarter,
these shares have fell -12.41%. Turning to look at the last 6 months, this
stock has dropped 27.41% to its price. Since the beginning of the calendar
year, this stock has moved down by 49.78%. |
|
P********6
发帖数: 709 | 44 Dynavax Combo Therapy Shows Response Rates of 70% in Melanoma
2018-06-04 18:15:00.0 GMT
By Cristin Flanagan
(Bloomberg) -- Dynavax’s SD-101 in combination with Merck & Co.’s
Keytruda showed an overall response rate (ORR) of 70%, or 21 out of 30
melanoma patients, at SD-101 doses less than or equal to 2mg. Results
excluded seven patients on study who had not yet had an imaging scan.
* 2mg has been selected as the dose of SD-101 to be tested in late-stage
melanoma setting
* An 8mg dose of SD-... 阅读全帖 |
|
s******i
发帖数: 350 | 45 From mid to long term, it will eventually go up.
For short term, I recommended CRTX recently.
However, it is up for more than 10% the two days.
So I would recommend to sell it now and possibly look for another wave
of CRTX.
For big potential, I strongly recommend DVAX. It will rush up like a rocket
at the end of this year. During the period, the trend will inch up.
I bought 2000 shares of DVAX in two different times including today.
The reason of DVAX to pop up is the very likely to be approved ... 阅读全帖 |
|
j*******7
发帖数: 349 | 46 以后想少发帖，多潜心学习，这个算是回报版面。
我跟过大夫的jnpr和fcel，跟过风云的dcth，dndn，dvax，abio， 和chtp，还跟过
luowei的mei 和fig，之外算是自己选的有bac, fb, fnma, fmcc, 和ltm，ghdx
jnpr和fcel都赚钱了，但是都出的太早，当时刚来古板，对大夫的技术背景不是很确认
，所以都是获利就跑。以后大夫的推荐还是会考虑的，不过一定会加入自己的判断。
dcth和dndn赚钱了，但是风险很大，这两个都是我获利以后几天就大跌的，所以觉得很
幸运。Dvax和abio都是给过我惨痛教训的，我在xiaoyaogu俱乐部里面发过贴说过。
Chtp刚刚跟，还不知道，但是目前觉得自己的入点很好。主要经验就是炒药股一定要有
耐心，等到好的入点。不然除非是fa很牛，心理过硬，是很难hold住的。
Mei和fig也都赚钱了，但是入点都不太好。因为当时luowei是去年发帖的，我今年才跟
。
最后说说自己选的，都赚钱了，但是ghdx很惊险，也是获利第二天就大跌，现在觉得这
个是烂股，当时获利完全是运气。 Ltm是我唯一个赌er的，但是没有经... 阅读全帖 |
|
发帖数: 1 | 47 DVAX,NVDA, GOOGLE潜水到再次高潮....
DVAX憋到30...
NVDA憋回原价....
Google随意反正不抛...
小额接飞刀，药物临床小赌，除外... |
|
|
y*****l
发帖数: 5997 | 49 报导日期：2011/12/20 12:09
美股周二盘中大涨
美股周二盘中大涨。新屋开工大幅改善有助於投资人信心，此外，德国的信心调查及西
班牙公债销售皆有助於市场表现，美股一甩昨天的疲态，开盘上扬大涨2%。
道琼工业指数盘中上涨269.96点，来到12036.15点，涨幅2.31%。那斯达克指数上涨70.
53点，来到2593.70点，涨幅2.80%。S&P 500上涨29.47点，来到1234.82点，涨幅2.45%
。
美国商务部周二公布，11月新屋开工成长9.3%，经季节性调整後年率为68.5万户，为
2010年四月以来最高。
Jefferies Group (JEF)第4季(11月为止)每股盈余0.17美元，合乎分析师预期的0.17美
元；净收入减少16.4%，为5.56亿美元，分析师预期5.6784亿美元。投资银行净收入为2
.61亿美元，上年度同期为2.92亿美元。
Swisher Hygiene(SWSH)宣布，已经收购FSR Transporting & Crane Services特定固体
废弃物与回收资产，支付110万美元现金。
Catalyst Pha... 阅读全帖 |
|
M*****8
发帖数: 17722 | 50 2013年7月9日最新的1688个看跌的股票。
多数到顶。墙街已深入插管，吸血在即。
排列依次为，号码，股票符号，收市价。
#0001, A , 44.6000
#0002, AA , 7.9010
#0003, AAGIY , 17.1600
#0004, AAMRQ , 4.7300
#0005, AAN , 28.9700
#0006, AAON , 24.7400
#0007, AAP , 83.2000
#0008, AAUKY , 9.5300
#0009, ABAX , 50.2800
#0010, ABCP , 1.0000
#0011, ABT , 34.7400
#0012, ACAT , 51.5000
#0013, ACE , 92.3800
#0014, ACGL , 52.3700
#0015, ACH , ... 阅读全帖 |
|
